Insider Trading & Ownership of Decheng Capital Global Life Sciences Fund IV, L.P.

Location: Grand Cayman, Cayman Islands
Summary: The estimated value of insider holdings of Decheng Capital Global Life Sciences Fund IV, L.P. is at least $175,343,522 dollars as of 19 Feb 2025. Decheng Capital Global Life Sciences Fund IV, L.P. is the 10%+ Owner of CG Oncology, Inc. and owns shares of CG Oncology, Inc. (CGON) stock worth about $175.34M.
Signature: Decheng Capital Global Life Sciences Fund IV, L.P., By Decheng Capital Management IV (Cayman), LLC, its General Partner, By /s/ Xiangmin Cui, Manager
All Insider Reports: All Insider Reports

Notify me when Decheng Capital Global Life Sciences Fund IV, L.P. files a new Insider Trading report.

Ownership of Decheng Capital Global Life Sciences Fund IV, L.P.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
CGON	CG Oncology, Inc.	10%+ Owner	$175,343,522			29 Jan 2024
AARD	Aardvark Therapeutics, Inc.	10%+ Owner				14 Feb 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.